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Frailty is a complex and dynamic condition associated with aging. This condition is characterised by the diﬃcult adaptation of
an old subject to new challenges occurring during life. Frailty is supposed to be due to the progressive decrease of physiological
reserves and multiorgan and multisystem change. It coincides with a reduced or absent resilience. In general comorbidities like
hypertension, heart disease, inﬂammation and infectious diseases are potential risk factors for and psychophysical decline. The
aim of this work is to highlight the importance of impaired cognition as factor predisposing to frailty. The authors are convinced
and suggest that the presence of neurobehavioral disturbance like apathy associated to impaired executive function could be the
major predisposing factor for frailty and unsuccessful aging. Unfortunately available literature largely underestimates the presence
of these factors. Thus to better identify markers of frailty, a good neuropsychological assessment and the evaluation of behavioural
disturbances are suggested.
1.Introduction
Aging is a complex phenomenon which features have re-
cently gained interest. In general aging is characterised by the
progressive accumulation of deﬁcits taking place in diﬀerent
individuals and in diﬀerent pathways (molecular, cellular,
psychological, and psychosocial, etc.), and with a variety of
rates proper of each individual, that may depend on the
interplay between intrinsic and extrinsic factors [1, 2].
Associated to aging we recognise a nonspeciﬁc condition
deﬁned “frail-old” or “frailty syndrome”. This is a condition
that has long been considered synonymous of disability and
comorbidity since it is prevalent in old age. Frailty is a con-
dition that expose an old subject to be vulnerable to many
non threatening-illness conditions, although they are not
recognised as precipitating factors [3, 4].
A good deﬁnition of normal aging, even in general terms
[5], may be useful to better understand the concept of frailty
and its features.
Normal aging is widely considered a physiological con-
dition during which natural reserves progressively decrease,
while still supporting an acceptable functioning of essential
organs, in a steady state. Thus aging is considered a dynamic
event in which a progressive dysregulation of homeostatic
conditions makes the organs and systems less or nonresilient
[6, 7].
Many variables (biologic, metabolic, psychosocial, etc.)
may play a signiﬁcant role in the evolution of aging process.
The association of these variables, which are diﬀerent among
individuals, with comorbidities (hypertension, heart disease,
diabetes, bone fractures, infectious diseases) are considered
responsible for the quality and rate of aging. Thus, the
absence of disabilities and unimpaired cognition might be
considered the features of successful aging [8]. Conversely,
unsuccessful aging could be the result of the association bet-
ween disabilities and cognitive decline. Considerable evi-
dence points to impairment of executive function as a key
contributor to age-related declines in a range of cognitive
tasks [9].
Therefore, frailty could be considered a dynamic condi-
tion set between successful and unsuccessful aging.
Following the “Frailty Task Force” of the American Geri-
atric Society frailty has been considered a clinical syndrome
deﬁned by the presence of 3 or more of the following symp-
toms: unintentional weight loss, self-reported exhaustion,
weakness, slow walking speed, and low physical activity.2 Journal of Aging Research
Clinical signs are represented by undernutrition, sarcopenia,
balance and gait disorders, and osteopenia. These features
are expected to hesitate in increased risk of falls, worsening
mobility or reducing it.
Severalconditionshavebeenidentiﬁedaspossiblyrelated
toafrailstatusandthusresponsiblealmostinpartfordecline
of old person.
Aging itself is generally accepted to be accompanied by
altered metabolic processes like increased free radicals pro-
duction, telomere shortening, and mitochondrial dysfunc-
tion; changes associated to extrinsic conditions like inﬂam-
matory status (IL-6, TNF; CRP) and common comorbidities
(chronic illness like diabetes, hypertension, coronary heart
disease, obesity, malignancies) may be responsible for frailty
and life-shortening [10–14]. In this view, frailty may be
considered as a condition which precedes in a subclinical
manner,suchthatwhenresilienceisoverwhelmeditbecomes
manifest concomitantly with the appearance of chronic
illness. At the same time altered resilience could be the
result of altered volition and motor planning, thus the
result of impaired executive functions. This in turn could be
responsible for hypomobility and reduced autonomy and as
a consequence might render someone frail that successfully
aged. In this view impaired cognition may be a precipitating
factor that shifts a subject from the prefrail to the frail status
[15].
The aim of this work is to discuss the role of altered
cognitive conditions of aged person and in particular we will
focus on executive functions and apathy in aging.
2. ExecutiveFunctions
Cognitive impairment is the primary determinant of disabi-
lity in late life, and at all ages, cognitive function is the
foundation of individual capacity to meet the challenges of
any disabling condition [16].
Executive functions refer to a variety of higher cognitive
processes that are related to the function of frontal lobes.
In general this area of the brain is able to integrate the
formation ﬂow arising from many sensory systems set in
bothanteriorandposteriorbrain,necessaryforgoal-directed
action and also for the control of attentional resources which
are considered basic for daily living activities [17]. In general
anterior parts of frontal lobes are involved in aspects of
self-regulation (inhibition or self-awareness) while posterior
parts are involved in reasoning process [18].
PFC and striatum are the main regions of the frontal
lobe involved in the control of executive functions [19, 20].
In both regions dopaminergic system plays an essential role
as a modulator of cortico-striatal functions, acting through
its receptors, namely, D1-like and D2-like [21–23]. Changes
of the dorsolateral prefrontal-caudate circuits are considered
responsible for disexecutive function, which lead mainly
to a subcortical dysfunction. Frontal lobes are involved in
the pathophysiology of many neurological and psychiatric
disorders and are also highly susceptible to changes of aging
[15, 24, 25].
During normal aging synaptic changes of frontal cortex
and associated to changes of the striatum (like altered
dendritic pruning, decrease of neurotransmitters eﬃciency,
in particular of dopaminergic system, and also the presence
of diﬀuse white matter lesions) [26] are considered re-
sponsible for poor performance on executive tasks in healthy
old subjects, as demonstrated in neuropsychological studies.
Moreover executive functions contribute also to motor
planning and therefore to maintain gait stability. As a con-
sequence an impairment of pre-frontal-striatal circuit could
be also responsible of gait instability and slow walking speed
observed in healthy old subjects.
Gait instability and slow speed during walking are con-
sidered risk factors for falls and disability.
Thus it is conceivable to suggest that, as depicted previ-
ously about the features of frail patient, impairment of ex-
ecutive functions during normal aging could represent the
marker to distinguish a successful aging from a prefrail sta-
tus, however not suﬃcient to determine frailty of a subject.
Our suggestion is that, more importantly, the presence of
apatheticbehaviorcouldrepresentreasonablyaprecipitating
factor for frailty.
3.Apathy andAging
Apathy is a behavioural syndrome common in normal phys-
iological aging and is also part of the psychiatric spectrum
of mental illness, and of many neurodegenerative disorders
like Alzheimer’s disease Apathy is an observable behavioural
syndrome consisting in a quantitative reduction of voluntary
(or goal-directed) behaviours [27]. Therefore, apathy occurs
when the systems that generate and control voluntary
actions are altered. In this view apathy can be deﬁned
as the quantitative reduction of self-generated voluntary
and purposeful behaviour and necessarily has not to be
considered a clinical aspect of depression (see [28, 29]).
Ingeneralthebasalgangliaandtheirconnectionwiththe
prefrontalcortexaredeputedtodecisionmaking.Hence,any
dysfunction of this frontostriatal circuit may be responsible
for apathetic behaviour.
Anatomical circuits of apathy are represented by cortical
areas like the prefrontal cortex (neo-, paleo-, and archeo-
cortex, amygdala, and hippocampus) and the ventral basal
ganglia (limbic striatum or better the nucleus accumbens,
midbrain ventral tegmental area, medial tip of subthalamic
nucleus, centromedian, and parafascicular nuclei of the
thalamus) [19, 30–32]. The roles played by prefrontal cortex
(PFC) and by nucleus accumbens (NAcc) render these
structures as the most involved in the appearance of apathy
[33, 34].
PFC has an essential role in cognitive and executive
processes that involve motivation, emotion learning, and
memory. PFC integrates sensory and limbic information and
promotes goal-directed behavior through eﬀerent projec-
tions to the NAcc. In addition, PFC sends outputs to other
limbic areas such as the hippocampus and amygdale, which
inturnmodulatetheactivityoftheNAccthroughexcitatory-
glutamatergic projections.
NAcc receives inputs from cortical areas (neocortex,
hippocampus, amygdala) and envy inputs to the ventral pal-
lidum,whichrepresentstheoutputnucleioftheventralbasalJournal of Aging Research 3
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Figure 1: Schematic representation of basal ganglia circuit. In this scheme the nucleus accumbens (NAcc) is an interface through which
limbic (glutamatergic) structures inﬂuence motor activity, in a way that limbic structures can inﬂuence behavior, under control of meso-
limbic (dopaminergic structures) system (Ventral Tegmental Area neurons).
ganglia system. This is a region that through its connection
with the thalamic nuclei transfers information back to the
cortex. This arrangement is made to select relevant signals
from background noise arising from multiple inputs and to
transfer it back to the cortex in order to generate output
signal to target nuclei. Put in this frame NAcc has been
proposed to play a role in emotion, and more generally
in limbic-motor integration (see Figure 1). This hypothesis
has been based on the anatomical organization of the NAcc
whichsuggeststhatthisnucleusisaninterfacethroughwhich
limbic (glutamatergic) structures inﬂuence motor activity,
and that these limbic inﬂuences on behavior could in part be
controlled by mesolimbic (dopaminergic structures) system.
Ideally any morphologic alteration in these brain regions can
potentially induce apathetic symptoms.
Following Levy and Dubois’s work [27], apathy has to
be considered heterogeneous disorder that may be ascribed
at least to three diﬀerent phenomena, each related to a
speciﬁc topography in basal ganglia. The ﬁrst involves
the aﬀective-emotional processing, thus the medial PFC
connection with amygdala and NAcc, the second involves
the cognitive processing, thus the lateral PFC and caudate
nucleus connection, and the third involves the so-called
“auto-activation” processing, which is observed in the severe
cases of apathy. In these cases a link with pallidal dysfunction
o extensive cortical lesions was supposed.
Duringnormalagingitisconceivabletosupposethatdue
to morphological and metabolic changes of cortical neurons
as well as of subcortical nuclei, disorder of emotional-
aﬀective processing may appear. PFC and hippocampus
have been demonstrated to show particular vulnerability
during normal aging. Subtle regional changes of dendritic
branching or altered mechanisms of neural plasticity have
been experimentally demonstrated in lab animals and also
in humans [35–39]. These changes are also associated
with reduced levels of neurotransmitters like acetylcholine,
glutamate, GABA, and dopamine decrease with age (Chen
et al. [40]). Such alterations may reasonably be responsible
for appearance of apathetic behavior in old subject. In this
view, several reports showed that dopamine transmission
is particularly vulnerable with age, in particular reduction
of the accumbal dopamine transporter and of cortical
dopamine receptors (both D1-like and D2-like, where D2-
like seems to be prevalent) in aged subjects ([41], Volkow
et al. [42]; Ishibashi et al. [43]; and B¨ ackman et al. [44]).
These changes were related to PFC cognitive deﬁcits and
in particular were related to executive function impairment
[45]. Even reward processing which has been demonstrated
to be tuned by dopamine is altered in aged subjects [44, 46,
47]. Thus, dopamine appears particularly as vulnerable to
aging.Giventheparticulardeﬁcitsofdopaminetransmission
and the role played by this transmitter in the control of PFC-
basal ganglia circuit, it is conceivable to suppose that such
changes could be responsible for apathetic behavior in old
subject. Moreover, apathy increases with age in healthy old
population [48], and its presence is considered an early sign
of cognitive decline [49].
4.The Apathyas Markerof Frail Status
Prefrailorfrailtysyndromeisconsidereddynamicconditions
where the reduced resilience of a subject might induce4 Journal of Aging Research
changes responsible for disability, hypomobility, and even
death.
Certainly the absence of disabilities and also preserved
cognition, as mentioned previously, represent the target for
a good aging.
Population-basedstudiesperformedinoldhealthyadults
demonstrated that only 30% of population examined can
be deﬁned as successfully aged [8]. About 70% of sub-
jects unfortunately suﬀer from several disabilities that may
shorten their life.
Certainly disabilities like diabetes, hypertension, and
heart disease of infections are easily identiﬁed and often
patient’s history shows how these were able to interfere
with aging compromising the possible recovery. Sarcopenia,
undernutrition, and inﬂammatory status are conditions that
m a yb ee a s i l ym e a s u r e d[ 3, 4].
Conversely cognition and neuropsychiatric disturbances
in healthy old subjects are infrequently evaluated among
old healthy subjects [50–52]. They are considered typical
disturbances of patients with frank cognitive decline and
thus evaluated among cognitively impaired patients, and
rarely among normally aged subjects [53]. Such condition
renders the weight of impaired cognition and of apathy on
nondemented healthy subjects underestimated.
Recently few studies [25, 54, 55] outlined the necessity
for measures of cognitive abilities and of neuropsychiatric
inventoryamongagedsubject.Indeed,thepresenceofapathy
during aging might be responsible for hypomobility and
reduced volition on one hand; on the other hand it may be
the principal cause of carelessness and as a consequence of
progressive worsening of comorbidities.
Inthisview,thepresenceofapathy,whichwearestrongly
convincedthatitisunderestimatedamongagedadults,could
represent the marker of a prefrail status predisposing a sub-
ject to become frail.
From our consideration emerges the need for further
studies to better identify the real impact of apathy and im-
paired executive functions on frailty syndrome.
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